Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4087)
All Articles published online
|
Dec 6, 2010 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gupta MK, Pollack S, Hutchings JJ. Mesalamine induced symptom exacerbation of ulcerative colitis: Case report and brief discussion. World J Gastrointest Pharmacol Ther 2010; 1(6): 132-134 [PMID: 21577308 DOI: 10.4292/wjgpt.v1.i6.132] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v1/i6/132.htm |
| Number | Citing Articles |
| 1 |
Ryan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, Kristine Højgaard Allin, Manasi Agrawal, Thomas Ullman, Jean-Frederic Colombel, Tine Jess. Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts. Gut 2019; 68(6): 977 doi: 10.1136/gutjnl-2018-317021
|
| 2 |
Matthew D Coates, Kofi Clarke, Emmanuelle Williams, Nimalan Jeganathan, Sanjay Yadav, David Giampetro, Vitaly Gordin, Sadie Smith, Kent Vrana, Anne Bobb, Thu Thi Gazzio, Heather Tressler, Shannon Dalessio. Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary Review. Crohn's & Colitis 360 2023; 5(4) doi: 10.1093/crocol/otad055
|
| 3 |
Shadi Hamdeh, Dejan Micic, Stephen Hanauer. Drug-Induced Colitis. Clinical Gastroenterology and Hepatology 2021; 19(9): 1759 doi: 10.1016/j.cgh.2020.04.069
|
| 4 |
Ceyda Tuna Kirsaclioglu, Zarife Kuloglu, Gonca Ustundag, Aydan Kansu, Erdal İnce, Arzu Ensari, Nurten Girgin. Mesalamine Intolerance in Three Children with Crohn's Disease. Medical Principles and Practice 2016; 25(3): 293 doi: 10.1159/000442946
|
| 5 |
Seth R. Shaffer, Elbert Huang, Shivani Patel, David T. Rubin. Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis. American Journal of Gastroenterology 2021; 116(1): 125 doi: 10.14309/ajg.0000000000000847
|
| 6 |
Ichiro Otani, Shiro Oka, Shinji Tanaka. Mesalazine‐induced enteritis causing refractory diarrhea. Digestive Endoscopy 2017; 29(1): 128 doi: 10.1111/den.12750
|
| 7 |
Jun Miyoshi, Katsuyoshi Matsuoka, Atsushi Yoshida, Makoto Naganuma, Tadakazu Hisamatsu, Tomoharu Yajima, Nagamu Inoue, Susumu Okamoto, Yasushi Iwao, Haruhiko Ogata, Fumiaki Ueno, Toshifumi Hibi, Takanori Kanai. 5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis. Intestinal Research 2018; 16(4): 635 doi: 10.5217/ir.2018.00015
|
| 8 |
Iva Hojsak, Ana M. Pavić, Sanja Kolaček. Mesalamine treatment mimicking relapse in a child with ulcerative colitis. World Journal of Pediatrics 2014; 10(4): 371 doi: 10.1007/s12519-014-0485-x
|
| 9 |
Hadi Mahmoudi-Moghaddam, Zahra Garkani-Nejad. A sensitive DNA biosensor for determination of mesalazine using PPy/Sponge-like Carbon/La3+-doped CuO nanocomposite. Journal of Materials Science: Materials in Electronics 2022; 33(10): 7487 doi: 10.1007/s10854-022-07886-7
|
| 10 |
Satohiro Matsumoto, Hirosato Mashima. Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-79207-z
|
| 11 |
Suresh Pola, Derek Patel, Sonia Ramamoorthy, Elisabeth McLemore, Marianne Fahmy, Jesus Rivera–Nieves, John T. Chang, Elisabeth Evans, Michael Docherty, Mark Talamini, William J. Sandborn. Strategies for the Care of Adults Hospitalized for Active Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2012; 10(12): 1315 doi: 10.1016/j.cgh.2012.07.006
|
| 12 |
Nancy Gupta, Stephen B. Hanauer. Too Soon to Discard 5-ASAs?. American Journal of Gastroenterology 2019; 114(3): 534 doi: 10.14309/ajg.0000000000000122
|
| 13 |
Bryan L Love, April D Miller. Extended-Release Mesalamine Granules for Ulcerative Colitis. Annals of Pharmacotherapy 2012; 46(11): 1529 doi: 10.1345/aph.1R171
|
| 14 |
Richa Chibbar, Alan C. Moss. Mesalamine in the Initial Therapy of Ulcerative Colitis. Gastroenterology Clinics of North America 2020; 49(4): 689 doi: 10.1016/j.gtc.2020.07.002
|
| 15 |
Yuki Minagawa, Kazuhiko Uchiyama, Tomohisa Takagi, Katsura Mizushima, Kohei Asaeda, Mariko Kajiwara-Kubota, Saori Kashiwagi, Yuma Hotta, Makoto Tanaka, Ken Inoue, Osamu Dohi, Tetsuya Okayama, Naohisa Yoshida, Kazuhiro Katada, Kazuhiro Kamada, Takeshi Ishikawa, Hiroaki Yasuda, Hideyuki Konishi, Yuji Naito, Yoshito Itoh. Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis. Journal of Clinical Biochemistry and Nutrition 2022; 71(3): 249 doi: 10.3164/jcbn.22-33
|
| 16 |
Maggie Ham, Alan C Moss. Mesalamine in the treatment and maintenance of remission of ulcerative colitis. Expert Review of Clinical Pharmacology 2012; 5(2): 113 doi: 10.1586/ecp.12.2
|
| 17 |
Prabhjot Singh Sidhu, Ravi Karwa, Victoria Kenneth, Debi Oxley, Anurag Agrawal. Which 5-ASA? Understanding the choices in ulcerative colitis therapy. Gastrointestinal Nursing 2014; 12(5): 17 doi: 10.12968/gasn.2014.12.5.17
|
| 18 |
Rumiko Tsuboi, Satohiro Matsumoto, Hiroyuki Miyatani, Hirosato Mashima. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis. Internal Medicine 2019; 58(5): 649 doi: 10.2169/internalmedicine.1607-18
|
| 19 |
Imuetinyan Asuen, Benjamin L. Cohen. The Hospitalized Adult with Severe Ulcerative Colitis. Hospital Medicine Clinics 2014; 3(4): 531 doi: 10.1016/j.ehmc.2014.06.004
|